Rule on sales of deferred VAs approved

The SEC has approved a FINRA rule intended to improve B-D sales practices for purchases and exchanges of deferred VAs.
SEP 10, 2007
The Securities and Exchange Commission has approved a new FINRA rule intended to improve broker-dealer sales practices for purchases and exchanges of deferred variable annuities. The rule, intended to protect senior citizens against financial fraud, is made up of four components. It imposes a suitability obligation tailored to the characteristics of deferred variable annuities. It contains standards for principal review and requires principals to review transactions before the customer's application is forwarded to the issuing insurance company for processing. It requires members to establish and maintain specific written supervisory procedures designed to achieve compliance with the standards set forth in the proposed rule. Finally, it requires members to develop and document specific training policies or programs designed to ensure compliance with the requirements of the rule and salespersons' understanding of the material features of deferred variable annuities. The SEC said it also issued an exemptive order allowing members of FINRA — The Financial Industry Regulatory Authority — to hold customer funds for no more than seven business days while completing the required principal review under the new rule without becoming fully subject to Exchange Act and being required to maintain higher levels of net capital.

Latest News

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor